Lee Pharma

Hyderabad, India Founded: 1997 • Age: 29 yrs
Pharmaceutical company focused on providing APIs, intermediates, and finished dosage forms
Annual revenue $45.0M Latest available
Total funding $5.7M 1 rounds
Employees 1381 Tracked headcount
Investors 1 Known backers
Products 4 Services tracked
Competitors 11 Brand Intelligence

About Lee Pharma

Lee Pharma is a company based in Hyderabad (India) founded in 1997 by Venkata Reddy Alla. Lee Pharma has raised $5.66 million across 1 funding round from investors including MOEHS. The company has 1,381 employees as of August 28, 2025. Lee Pharma offers products and services including Active Pharmaceutical Ingredients, Intermediate Chemicals, Finished Formulations, and CDMO Services. Lee Pharma operates in a competitive market with competitors including Almac Group, Indoco Remedies, Concord Biotech, BDR Pharmaceuticals Internationals and Aurobindo Pharma, among others.

  • Headquarter Hyderabad, India
  • Employees 1381 as on 28 Aug, 2025
  • Founders Venkata Reddy Alla
  • Stage Minicorn
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Lee Pharma Limited
  • Date of Incorporation 06 Oct, 1997
  • Jurisdiction Hyderabad, Telangana, India
Operational Areas
Healthcare → Healthcare Services & Infrastructure Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $44.96 M (USD)
    37.6
    as on Mar 31, 2020
  • Net Profit
    $1.69 M (USD)
    -0.3
    as on Mar 31, 2020
  • EBITDA
    $4.42 M (USD)
    19.83
    as on Mar 31, 2020
  • Total Equity Funding
    $5.66 M (USD)

    in 1 rounds

  • Latest Funding Round
    $5.66 M (USD), Series A

    Jun 09, 2007

  • Investors
  • Employee Count
    1381

    as on Aug 28, 2025

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Lee Pharma

Lee Pharma offers a comprehensive portfolio of products and services, including Active Pharmaceutical Ingredients, Intermediate Chemicals, Finished Formulations, and CDMO Services.

Product name locked
Category locked
Primary

High-quality APIs for drug manufacturing and global supply.

Product name locked
Category locked
Locked

Essential intermediates used in pharmaceutical production processes.

Product name locked
Category locked
Locked

Ready-to-use formulations for various therapeutic applications.

Product name locked
Category locked
Locked

Custom development and manufacturing services for pharmaceuticals.

Funding Insights of Lee Pharma

Lee Pharma has successfully raised a total of $5.66M through 1 strategic funding round. The most recent funding activity was a Series A round of $5.66 million completed in June 2007. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investors in Lee Pharma

Lee Pharma has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include MOEHS.

All
Institutional
Investor Description Founded Year Domain Location
Produces high-quality chemicals for the pharmaceutical industry.
Locked Locked Locked
Premium access

Investor details for Lee Pharma

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Lee Pharma

Investments
Premium access

Investment portfolio details for Lee Pharma

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Lee Pharma

Premium access

Detailed financials for Lee Pharma

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Lee Pharma Comparisons

Lee Pharma Primary company
Description
Pharmaceutical company focused on providing APIs, intermedia...
Location
Hyderabad, India
Founded Year
1997
Annual Revenue
$44.96 M (USD)
Net Profit
$1.69 M (USD)
EBITDA
$4.42 M (USD)
Employees
1,381
As of 2025
Premium access

Peer comparison for Lee Pharma

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Lee Pharma

Lee Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Almac Group, Indoco Remedies, Concord Biotech, BDR Pharmaceuticals Internationals and Aurobindo Pharma, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Integrated CDMO services for biopharma R&D and manufacturing are offered.
Locked Locked Locked
APIs manufacturing and formulation services are provided in therapeutic segments.
Locked Locked Locked
APIs and enzymes are manufactured through fermentation by the CDMO.
Locked Locked Locked
APIs and finished products are developed and manufactured.
Locked Locked Locked
Generic biocatalytic solutions are provided for pharmaceutical applications.
Locked Locked Locked
APIs and peptides are developed and manufactured by Asymchem.
Premium access

Detailed competitors of Lee Pharma

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Lee Pharma

Premium access

Complete news archive for Lee Pharma

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Lee Pharma

Lee Pharma was founded in 1997 and raised its 1st funding round 10 years after it was founded.

Lee Pharma is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.

Lee Pharma is a funded company, having raised a total of $5.66M across 1 funding round to date.

As of Aug 28, 2025, the latest employee count at Lee Pharma is 1,381.

Annual revenue of Lee Pharma is $44.96M as on Mar 31, 2020.

Lee Pharma was established in 1997 in Hyderabad, India, within the pharmaceutical sector. Operations center on the production and supply of active pharmaceutical ingredients (APIs), key intermediates, and finished dosage forms. The company serves global markets through its manufacturing facilities, emphasizing compliance with regulatory standards for quality and safety in drug development and distribution. Leadership is provided by founder Venkata Reddy Alla as Managing Director.

Lee Pharma's top competitors include Concord Biotech, BDR Pharmaceuticals Internationals and Almac Group.

Lee Pharma offers Active Pharmaceutical Ingredients, Intermediate Chemicals, Finished Formulations, and CDMO Services.

Lee Pharma has 1 investor. Key investors include MOEHS.

The valuation of Lee Pharma is $12.93M as of Jun 2007.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available